GTS5:Table of Contents: Difference between revisions
| [checked revision] | [checked revision] |
Bailey.Glen (talk | contribs) No edit summary |
Bailey.Glen (talk | contribs) No edit summary |
||
| Line 72: | Line 72: | ||
==Cell cycle and apoptosis pathways ([[GTS5:Cell cycle and apoptosis pathways|Overview Page Link]])== | ==Cell cycle and apoptosis pathways ([[GTS5:Cell cycle and apoptosis pathways|Overview Page Link]])== | ||
'''P53 pathway''' | '''P53 pathway''' | ||
- [[GTS5:Li-Fraumeni syndrome (TP53)]] | - [[GTS5:Li-Fraumeni syndrome (TP53)]] | ||
| Line 85: | Line 85: | ||
==DNA repair and genomic stability ([[GTS5:DNA repair and genomic stability|Overview Page Link]])== | ==DNA repair and genomic stability ([[GTS5:DNA repair and genomic stability|Overview Page Link]])== | ||
'''Mismatch repair''' | '''Mismatch repair''' | ||
- [[GTS5:Lynch Syndrome (MLH1, PMS2, MSH2, MSH6)]] | - [[GTS5:Lynch Syndrome (MLH1, PMS2, MSH2, MSH6)]] | ||
| Line 126: | Line 127: | ||
==Telomere maintenance ([[GTS5:Telomere maintenance|Overview Page Link]])== | ==Telomere maintenance ([[GTS5:Telomere maintenance|Overview Page Link]])== | ||
'''Telomere biology disorders''' | '''Telomere biology disorders''' | ||
- [[GTS5:Dyskeratosis congenita (DKC1, TERT, TERC, TINF2, Other IBMFS genes)]] | - [[GTS5:Dyskeratosis congenita (DKC1, TERT, TERC, TINF2, Other IBMFS genes)]] | ||
| Line 132: | Line 134: | ||
==Epigenetic drivers and chromatin remodelling ([[GTS5:pigenetic drivers and chromatin remodelling|Overview Page Link]])== | ==Epigenetic drivers and chromatin remodelling ([[GTS5:pigenetic drivers and chromatin remodelling|Overview Page Link]])== | ||
'''Imprinting disorders''' | '''Imprinting disorders''' | ||
- [[GTS5:Beckwith-Wiedemann spectrum (IGF2; CDKN1C)]] | - [[GTS5:Beckwith-Wiedemann spectrum (IGF2; CDKN1C)]] | ||
| Line 146: | Line 148: | ||
==RNA regulation ([[GTS5:RNA regulation|Overview Page Link]])== | ==RNA regulation ([[GTS5:RNA regulation|Overview Page Link]])== | ||
'''MicroRNA''' | '''MicroRNA''' | ||
- [[GTS5:DICER1-related tumour predisposition syndrome (DICER1)]] | - [[GTS5:DICER1-related tumour predisposition syndrome (DICER1)]] | ||
- [[GTS5:MicroRNA processor tumour predisposition syndromes (DROSHA, DGCR8)]] | - [[GTS5:MicroRNA processor tumour predisposition syndromes (DROSHA, DGCR8)]] | ||
| Line 155: | Line 157: | ||
==Protein regulation ([[GTS5:Protein regulation|Overview Page Link]])== | ==Protein regulation ([[GTS5:Protein regulation|Overview Page Link]])== | ||
'''Ubiquitin pathway''' | '''Ubiquitin pathway''' | ||
- [[GTS5:BAP1-related tumour predisposition syndrome (BAP1)]] | - [[GTS5:BAP1-related tumour predisposition syndrome (BAP1)]] | ||